These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12749246)

  • 41. Insulin resistance in the first-degree relatives of persons with type 2 diabetes.
    Straczkowski M; Kowalska I; Stepień A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I; Krukowska A; Konicka M
    Med Sci Monit; 2003 May; 9(5):CR186-90. PubMed ID: 12761455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relation between insulin resistance and amount of visceral adipose tissue].
    Bajzová M; Kováciková M; Vítková M; Polák J; Klimcáková E; Srp A; Vedral T; Mikulásek L; Srámková SP; Stich V; Hejnová J
    Cas Lek Cesk; 2008; 147(7):376-80. PubMed ID: 18678096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
    Nair S; Diehl AM; Wiseman M; Farr GH; Perrillo RP
    Aliment Pharmacol Ther; 2004 Jul; 20(1):23-8. PubMed ID: 15225167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of triglyceride and insulin resistance in patients with nonalcoholic steatohepatitis.
    Basaranoglu M
    Can J Gastroenterol; 2002 Nov; 16(11):813-4; author reply 814. PubMed ID: 12464976
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin resistance in non-alcoholic steatohepatitis.
    Cömert B; Mas MR; Erdem H; Dinc A; Saglamkaya U; Cigerim M; Kuzhan O; Unal T; Kocabalkan F
    Dig Liver Dis; 2001 May; 33(4):353-8. PubMed ID: 11432515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin resistance and endothelial dysfunction in type 2 diabetic patients with non-alcoholic steatohepatitis.
    Kawashima S; Suzuki M; Kaneto H; Imano E; Haruna Y; Nishimura Y; Kawashima A; Hatazaki M; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabet Med; 2009 Jun; 26(6):661-3. PubMed ID: 19538246
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis.
    Tankurt E; Biberoglu S; Ellidokuz E; Hekimsoy Z; Akpinar H; Cömlekçi A; Okan A; Sagol O
    J Hepatol; 1999 Nov; 31(5):963. PubMed ID: 10580597
    [No Abstract]   [Full Text] [Related]  

  • 50. [Improving insulin resistance: certain progress in the management of patients with non-alcoholic steatohepatitis...but the story continues].
    Cadranel JF; Jouannaud V; Loison S
    Gastroenterol Clin Biol; 2004 Mar; 28(3):265-7. PubMed ID: 15094675
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical update on non-alcoholic fatty liver disease and steatohepatitis.
    Bugianesi E; Bellentani S; Bedogni G; Tiribelli C;
    Ann Hepatol; 2008; 7(2):157-60. PubMed ID: 18626435
    [No Abstract]   [Full Text] [Related]  

  • 52. [Influence of malnutrition on insulin resistance in cirrhotic patients, studied with the euglycemic clamp].
    Gastroenterol Clin Biol; 1989 May; 13(5):527-8. PubMed ID: 2666242
    [No Abstract]   [Full Text] [Related]  

  • 53. Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue.
    Angulo P; Lindor KD
    Gastroenterology; 2001 Apr; 120(5):1281-5. PubMed ID: 11266392
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonalcoholic steatohepatitis.
    Sanyal A
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C64-70. PubMed ID: 11293184
    [No Abstract]   [Full Text] [Related]  

  • 55. [Non-alcoholic steatohepatitis (NASH). 2. Insulin resistance and NASH].
    Saibara T; Ono M; Onishi S
    Nihon Naika Gakkai Zasshi; 2006 Jan; 95(1):46-50. PubMed ID: 16499207
    [No Abstract]   [Full Text] [Related]  

  • 56. [Porphirin metabolism in non-alcoholic steatohepatitis].
    Krivosheev AB; Kuimov AD; Morozov DV; Krivosheeva IA; Gmyza OA
    Ter Arkh; 2008; 80(11):64-8. PubMed ID: 19143196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin resistance and oxidative stress: two therapeutic targets in non-alcoholic steatohepatitis.
    Voican CS; Perlemuter G
    J Hepatol; 2011 Feb; 54(2):388-91. PubMed ID: 21112115
    [No Abstract]   [Full Text] [Related]  

  • 58. Erratum to "Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis" by Park BH, et al. (Yonsei Med J 2017;58:756-762.).
    Yonsei Med J; 2018 May; 59(3):461. PubMed ID: 29611411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian survey.
    Assem M; Yousri M
    Int J Hepatol; 2011; 2011():530949. PubMed ID: 21994862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors.
    Yamada Y; Noborisaka Y; Ishizaki M; Tsuritani I; Honda R
    Environ Health Prev Med; 2004 Nov; 9(6):243-50. PubMed ID: 21432309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.